Exploring innovations in cardiovascular medicine at TCT MedTech Forum

As the pace of change accelerates in healthcare, the most pressing questions in cardiovascular medicine demand immediate answers.

Bristol Myers uncorks positive PhIII readout for subcutaneous Opdivo

Bristol Myers Squibb’s subcutaneous formulation of its cancer blockbuster Opdivo proved noninferior to intravenous Opdivo in a Phase III trial, the company announced on Thursday.

October 20, 2023

A Q&A with the FDA’s top vaccine regulator amid a fresh wave of disinformation

Vaccination policy in the United States could be in line for some fundamental changes, if Donald Trump is reelected and delivers on promises that long-time

November 4, 2024

How dietary restrictions, including intermittent fasting, impact gut microbiota and overall human health

Preclinical and clinical data to analyze gut microbial alterations in various dietary conditions.

December 5, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.